NO20030156L - Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav - Google Patents

Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav

Info

Publication number: NO20030156L
Authority: NO; Norway
Prior art keywords: methods; pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 2000-07-14

Application number

NO20030156A

Other languages

English (en)

Other versions

NO20030156D0 (no

Inventor

Gary Maurice Dull

Original Assignee

Targacept Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-14

Filing date

2003-01-13

Publication date

2003-03-13

2003-01-13 Application filed by Targacept Inc filed Critical Targacept Inc

2003-01-13 Publication of NO20030156D0 publication Critical patent/NO20030156D0/no

2003-03-13 Publication of NO20030156L publication Critical patent/NO20030156L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20030156A 2000-07-14 2003-01-13 Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav NO20030156L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/616,187 US6743812B1 (en)	2000-07-14	2000-07-14	Pharmaceutical compositions and methods for use
PCT/US2001/040689 WO2002005801A2 (en)	2000-07-14	2001-05-04	Compositions containing diacyltartaric salts of (e)-metanicotine

Publications (2)

Publication Number	Publication Date
NO20030156D0 NO20030156D0 (no)	2003-01-13
NO20030156L true NO20030156L (no)	2003-03-13

Family

ID=24468381

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030156A NO20030156L (no)	2000-07-14	2003-01-13	Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav

Country Status (13)

Country	Link
US (1)	US6743812B1 (no)
EP (1)	EP1317267A2 (no)
JP (1)	JP2004503589A (no)
CN (1)	CN1452486A (no)
AU (1)	AU2001261828A1 (no)
BR (1)	BR0112131A (no)
CA (1)	CA2415906A1 (no)
HU (1)	HUP0301594A2 (no)
IL (1)	IL153487A0 (no)
NO (1)	NO20030156L (no)
PL (1)	PL365602A1 (no)
WO (1)	WO2002005801A2 (no)
ZA (1)	ZA200300132B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6979695B2 (en) *	1996-04-23	2005-12-27	Targacept, Inc.	Compounds capable of activating cholinergic receptors
US6708064B2 (en) *	2000-02-24	2004-03-16	Ali R. Rezai	Modulation of the brain to affect psychiatric disorders
US6432954B1 (en) *	2000-07-14	2002-08-13	Targacept, Inc.	Pharmaceutical compositions and methods for use
US7459469B2 (en) *	2004-11-10	2008-12-02	Targacept, Inc.	Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru) *	2004-11-10	2009-11-25	Таргасепт, Інк.	Гидроксибензоатные соли метаникотиновых соединений
TWI389889B (zh) *	2006-05-09	2013-03-21	Targacept Inc	（２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
EP2133337A1 (en) *	2006-05-09	2009-12-16	AstraZeneca AB	Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine
AR062860A1 (es) *	2006-09-15	2008-12-10	Astrazeneca Ab	Combinaciones terapeuticas 482
JP5502494B2 (ja) *	2007-01-22	2014-05-28	ターガセプト・インコーポレイテッド	メタニコチンアナログの鼻腔内、バッカル、または舌下投与
EP2182932A2 (en) *	2007-07-31	2010-05-12	Targacept Inc.	Transdermal administration of (2s)-(4e)-n-methyl-5-(3-(5-isopropoxypyridin)yl)-4-penten-2-amine
CN103180277A (zh) *	2010-05-20	2013-06-26	塔格塞普特股份有限公司	制备芳基取代的烯属胺的新方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1409551A (en)	1972-04-14	1975-10-08	Allen & Hanburys Ltd	Cyclopent a indene derivatives
US4528290A (en)	1984-01-30	1985-07-09	Eli Lilly And Company	Stimulating dopamine D-1 receptors
GB8606254D0 (en)	1986-03-13	1986-04-16	Wyeth John & Brother Ltd	Substituted pyrimidoindoles
FR2664600B1 (fr)	1990-07-16	1994-09-02	Rhone Poulenc Sante	Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.
US5723477A (en)	1994-11-10	1998-03-03	Sibia Neurosciences, Inc.	Modulators of acetylcholine receptors
MX9703988A (es) *	1994-12-12	1998-02-28	Omeros Med Sys Inc	SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
JP3899126B2 (ja)	1995-01-06	2007-03-28	ターガセプト，インコーポレイテッド	中枢神経系疾患の予防及び治療のための医薬組成物
CA2197838C (en) *	1996-03-01	2004-09-28	Mark S. Miller	Mouthfeel and lubricity enhancing composition
US5663356A (en)	1996-04-23	1997-09-02	Ruecroft; Graham	Method for preparation of aryl substituted alefinic secondary amino compounds

2000
- 2000-07-14 US US09/616,187 patent/US6743812B1/en not_active Expired - Fee Related
2001
- 2001-05-04 IL IL15348701A patent/IL153487A0/xx unknown
- 2001-05-04 PL PL01365602A patent/PL365602A1/xx unknown
- 2001-05-04 EP EP01935766A patent/EP1317267A2/en not_active Withdrawn
- 2001-05-04 WO PCT/US2001/040689 patent/WO2002005801A2/en not_active Application Discontinuation
- 2001-05-04 JP JP2002511734A patent/JP2004503589A/ja not_active Withdrawn
- 2001-05-04 CN CN01812810A patent/CN1452486A/zh active Pending
- 2001-05-04 BR BR0112131-6A patent/BR0112131A/pt not_active Application Discontinuation
- 2001-05-04 AU AU2001261828A patent/AU2001261828A1/en not_active Abandoned
- 2001-05-04 HU HU0301594A patent/HUP0301594A2/hu unknown
- 2001-05-04 CA CA002415906A patent/CA2415906A1/en not_active Abandoned
2003
- 2003-01-06 ZA ZA200300132A patent/ZA200300132B/en unknown
- 2003-01-13 NO NO20030156A patent/NO20030156L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2002005801A2 (en)	2002-01-24
US6743812B1 (en)	2004-06-01
ZA200300132B (en)	2004-04-06
EP1317267A2 (en)	2003-06-11
WO2002005801A3 (en)	2002-08-08
JP2004503589A (ja)	2004-02-05
NO20030156D0 (no)	2003-01-13
IL153487A0 (en)	2003-07-06
AU2001261828A1 (en)	2002-01-30
CA2415906A1 (en)	2002-01-24
PL365602A1 (en)	2005-01-10
BR0112131A (pt)	2003-09-02
HUP0301594A2 (hu)	2003-08-28
CN1452486A (zh)	2003-10-29

Publication	Publication Date	Title
DK1202941T3 (da)	2007-09-17	Gipssammensætninger og beslægtede fremgangsmåder
DK1242095T3 (da)	2013-08-12	Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
DK1329456T3 (da)	2006-12-04	Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
DK1353919T3 (da)	2006-11-20	Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657A (fi)	2010-06-10	Farmaseuttisia koostumuksia
DK1417175T3 (da)	2013-10-28	Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
IS6934A (is)	2003-08-29	Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
NO20025450L (no)	2002-11-14	Ny farmasöytisk sammensetning
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DK1251848T3 (da)	2004-10-18	Gyraseinhibitorer og anvendelse deraf
DK1354888T3 (da)	2009-09-21	Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
DK1339292T3 (da)	2010-04-12	Sammensætning og fremgangsmåde
DK1429769T3 (da)	2009-05-11	Nye formuleringer og anvendelse deraf
IS2841B (is)	2013-08-15	Samstæða hluta og lyfjasamsetningar
NO20025158D0 (no)	2002-10-25	Lipidpreparat og anvendelse derav
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
NO20034778D0 (no)	2003-10-24	Farmasöytiske sammensetninger for oral og topisk anvendelse
NO20043333L (no)	2004-09-13	Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem
NO20030156D0 (no)	2003-01-13	Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20031095D0 (no)	2003-03-10	Farmasöytiske sammensetninger
NO20022022L (no)	2002-04-29	N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse

Legal Events

Date	Code	Title	Description
2005-01-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application